We read with great interest the articles of Fabre and Dereure on 'Worsening alopecia areata and de novo occurrence of multiple halo nevi in a patient receiving infliximab' [1] and of Pelivani et al. on 'Alopecia areata universalis elicited during treatment with adalimumab' [2] , and we want here to report on a similar observation of a rapidly progressive alopecia areata (AA) during treatment with adalimumab for rheumatoid arthritis (RA).
Case Report
A 38-year-old woman with RA from the age of 15 years had been treated with adalimumab and methotrexate for 1 year and then with adalimumab alone for another year, with an excellent control of RA. She suddenly developed a rapid course of extensive hair loss resulting within 3 months in a typical form of AA universalis. There was no evident triggering factor (infection, stress or trauma), and she had no personal or familial history of AA. There were no other complaints, and the clinical examination was normal. The decision to stop adalimumab was made after consulting her rheumatologist.
Comments
AA is a nonscarring autoimmune hair loss condition frequently recurrent and resistant to treatment [3] . Although its pathophysiology remains unknown, it is postulated that CD4+ and CD8+ T cells reactive to hair bulb autoantigens induce the inflammatory process leading to hair loss [3, 4] . In this respect, AA is frequently associated with other autoimmune diseases such as insulin-dependent diabetes, RA, vitiligo or Hashimoto's disease. The present observation together with that of Pelivani et al. [2] suggests that adalimumab could trigger AA in predisposed individuals. The rapid development of AA in our patient may also be related to the interruption of methotrexate, an effective treatment of AA [5] , which was associated with adalimumab for 1 year prior to the onset of the disease.
The role of TNF-␣ in the pathophysiology of autoimmunity, and more specifically of AA, appears complex. On the one hand, TNF-␣ was considered an important cytokine involved in the hair loss, the more so because it inhibits hair growth in vitro and TNF-␣ -producing cells can be found in the mononuclear infiltrate
